RxDoctor Payments Data

Henri Roukoz, MD

Clinical Cardiac Electrophysiology · Minneapolis, MNNPI 1144499187

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $16,170 of the $24,703 with a category attached, or 65.5%. Medtronic accounts for 85.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $11,658 and has fallen 76.5% since, to $2,741 in 2025.

$24,703in general payments, 2019–2025

Across 141 payments — averaging $175.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$21K
  • Biosense Webster, Inc.$2K
  • Boston Scientific$643
  • ZOLL Respicardia, Inc.$516
  • Abbott$349
  • Biotronik Inc.$320
  • plus $151 from 2 others
$376,521in research payments, 2019–2025

Across 73 payments — averaging $5157.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$377K

What the payments were for

  • Consulting fees$7503%
  • Speaking & faculty fees$2,50010%
  • Travel & lodging$16,17065%
  • Food & beverage$5,28321%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,703 in reported general payments places this provider in the 70th percentile of 72 clinical cardiac electrophysiology providers in Minnesota.

See all clinical cardiac electrophysiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$187,711
Medicare patients
2,171
Services billed
4,923

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban174$236,361
XareltoRivaroxaban39$57,012
Metoprolol Succinate174$4,039
Amiodarone Hcl165$3,898
Flecainide Acetate60$2,778
Mexiletine Hcl15$2,138
SotalolSotalol Hcl53$1,646
Diltiazem 24hr Er (Cd)Diltiazem Hcl68$1,349
Nadolol18$1,023
Losartan Potassium33$736
Carvedilol38$524
Ranolazine ErRanolazine14$371
Warfarin Sodium16$317
Lisinopril19$249
Atorvastatin Calcium17$228

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →